U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07343973) titled 'Post-Market Study on the Safety and Effectiveness of the OpHLINE OVD in Cataract Surgery' on Jan. 07.
Brief Summary: This post-market clinical study was designed to assess the safety and effectiveness of the OpHLINE Ophthalmic Viscosurgical Device (OVD) as an adjunct in cataract surgery. OpHLINE is a sterile, viscoelastic solution based on high-molecular-weight sodium hyaluronate, intended to maintain the anterior chamber space and protect corneal endothelial cells during phacoemulsification and intraocular lens (IOL) implantation.
The hypothesis is that OpHLINE, available in three concentrations (1.4%, 2%, and 3%), will provide op...